Article
NYT: Marco Rubio Running Venezuela From Washington
Secretary of State Marco Rubio controls Venezuela’s finances, making him the effective viceroy of the South American nation. “Mr. Rubio has become the de facto viceroy of Venezuela, holding sway over a sovereign nation in a way that no American official has since Paul Bremer III arrived in Baghdad in 2003 to run US-occupied Iraq,” […]
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Jun 26, 2026 / Jacob G. Hornberger
The Imperative of a US Conviction in the Maduro Case
Having illegally attacked Venezuela in an effort to kidnap the country’s president, Nicolás Maduro, and transport him to the United States to stand trial for supposed violations of US drug laws, US officials have placed themselves in a position in which they are now compelled to secure a conviction. After all, how is it going […]
Read more
May 21, 2026 / Tyler Durden
Pentagon Delegation's Beijing Visit Held Up Over Gargantuan US Arms Package For Taiwan
Pentagon Delegation's Beijing Visit Held Up Over Gargantuan US Arms Package For Taiwan
China is using a Pentagon itinerary as structural leverage, and Taiwan remains front and center as the key geopolitical snag in bettering communications and relations between Beijing and Washington.
According to a Financial Times report published Thursday, China is actively holding up a proposed visit by Elbridge Colby, the Pentagon's under-secretary of defense for policy. The move is a transparent effort to pressure President Trump over a looming $14 billion weapons package for Taiwan.
Elbridge Colby, left.
While Colby had...
Read more
Aug 3, 2026 / Tyler Durden
$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"
$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"
The Financial Times reported overnight that AstraZeneca has explored acquiring Bristol Myers Squibb in a potential megadeal that would create one of the world's largest drugmakers, with a combined market capitalization of nearly $400 billion.
The report cited people familiar with the matter, while both pharmaceutical giants declined to comment. Some Wall Street desks, however, are struggling to see the strategic rationale behind such a combination.
FT reported:
The companies have held discussions about a tie-up in recent months, according...
Read more




